Your browser doesn't support javascript.
loading
An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
Ayse Ornek, Sinem; Orcen, Cihan; Church, Martin K; Kocaturk, Emek.
Afiliación
  • Ayse Ornek S; Department of Dermatology, Health Sciences University Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
  • Orcen C; Department of Allergy Immunology, Health Science University Derince Training and Research Hospital, Kocaeli, Turkey.
  • Church MK; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kocaturk E; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Dermatology, Koc University School of Medicine, Istanbul, Turkey; Fraunhofer Institute for Translational Medicine and Pharm
Int Immunopharmacol ; 112: 109198, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36115277
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antagonistas de los Receptores Histamínicos H1 no Sedantes / Urticaria Crónica Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antagonistas de los Receptores Histamínicos H1 no Sedantes / Urticaria Crónica Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía